Journalists from China, Germany, India and Kenya have been recognised for their outstanding articles on cancer in the 2016 Cancer World Journalism Awards. The awards, organised by the European School of Oncology’s Cancer World magazine, [more]
As ECCO’s new President-elect, Philip Poortmans is the first person to have a full democratic mandate from across all ECCO’s 24 member societies which, between them, represent the full range of healthcare professionals involved in [more]
In women hit by breast cancer, the size and type of social relationships influence the rates of recurrence and mortality, according to a research published on Cancer, a peer-reviewed journal of the American Cancer Society. [more]
In the last decade, cancer cases increased worldwide by 33 percent, mostly due to population aging, population growth and changes in age-specific cancer rates: this is one of the key conclusions of the new report [more]
Efforts to establish a new comprehensive cancer research center in Athens as part of the National Hellenic Research Foundation are underway, according to the director of the foundation, Dr. Vasilis Gregoriou. The National Hellenic Research [more]
The deadline for applying for a journalist grant to the ECCO congress has been extended. The new deadline is Wednesday 16th November Reporting on Cancer ESO @ #ECCOCongress Fellowship 27-30 January 2017 Amsterdam The European [more]
Umberto Veronesi passed away on the 8th of November, after an entire life dedicated to the fight against cancer, to surgery, to advocacy, to research. He died in peace, fading away with his unique and [more]
Not so long ago, research protocols excluded older cancer patients based on chronologic age. Now they exclude patients with comorbidities, and as most older patients suffer additional ailments, they do not fit the protocols. But [more]
For most of us, sooner or later, old age will bring frailty and chronic health conditions, making the task of living the life we wish progressively harder. We will want oncologists who know what different [more]
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid delaying too [more]
Prioritising collaboration over self-interest is the way to learn about who gets the best from which treatments in the complex world of advanced prostate cancer. Silke Gillessen talked to Simon Crompton about how she is [more]
It makes no sense to perform clinical research that has no relevance to patient care, so why do we do it, and how can we stop? John Ioannidis ponders the problem and offers some suggestions. [more]
The state of the art on the diagnosis and management of cancer of the pancreas and hepatobiliary system was the focus of the 3rd St Gallen Gastrointestinal Cancer Conference, held earlier this year under the [more]